sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Healthcare / In-Vitro Toxicology Testing

In-Vitro Toxicology Testing Market: By Product (Consumables, Assays, Equipment, Software, & Services), By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, & OMICS Technology), By Method (Cellular Assay, Biochemical Assay, In silico, & Ex-vivo), By Application (Systemic Toxicology, Dermal Toxicology, Endocrine Disruption, Ocular Toxicity, & Others), By End-User (Pharmaceutical, Cosmetics and Household Products, Diagnostics, Chemicals Industry, & Food industry), And By Regions – Global And Regional Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026

  • Publish On: Jun-2021
  • Total Pages: 183
  • Report Code: FAF-1498
  • Base Year: 2020
  • Format:

Industry Insights

[183+ Pages Report] We recently published a new market report named global In-vitro Toxicology Testing Market which incorporates the most recent offers. With a CAGR of 10.7%, we anticipate a market value of USD 9.7 Billion in 2020, rising to USD 16.1 Billion in 2026.

Global In-Vitro Toxicology Testing Market: Overview

In-vitro toxicology refers to the scientific breakdown of the compounding effect that toxic chemical substances has on a batch of cultured bacterial arrays or any set of mammalian cells. In-vitro refers to methods and procedures that are potentially used for identification of hazardous chemicals and/or to confirm the lack of certain toxic traits in the initial stages of developing new substances for a range of therapeutic, agricultural, and food additives compounds. Various global organizations across the globe often incorporate in-vitro toxicology testing methods in order to better prepare risk assessment reports on the human anatomy.

Global In-Vitro Toxicology Testing Market: Growth Factors

The primary driving factors for the growth of the in-vitro toxicology testing market are the intense evolution of 3D cell culture systems that render the host physiology that ensures potentially limitless testing of the human compound without any real-life animal testing. Factors pertaining to a risen acceptance of in-vitro toxicology and improvement in statistical computing models and simulations will further drive the growth of the market. Additional factors that can significantly boost the growth of the in-vitro toxicology testing market can be contributed toward a driven interest in developing better high-throughput screening (HTS) which further enables manufacturers to produce a cheaper and cost-effective testing alternative.

Moreover, factors such as a rise in checking drug testing and manufacturing measures, a rise in the safety of consumables, increased screening during production, and a generalized trend of increase of in-vitro testing have been observed. These factors will contribute heavily in opening new revenue opportunities for in-vitro toxicology testing market globally. Advancements in the technology have led to features such as early detection of drug safety standards which will further boost the growth of the market during the forecast. The rise in targeted focus such as drug discovery solutions and a rising trend of personalized medicine will push the market toward a ballooned state. Rising ethical concerns regarding animal testing procedures and efforts undertaken by global organizations can hamper the growth of the market to a certain extent.

Global In-Vitro Toxicology Testing Market: Segmentation

The global in-vitro toxicology testing market can be segmented on the basis of product, technology, method, application, end-users, and regions.

On the basis of the product, the global in-vitro toxicology testing market can be divided into consumables, assays, equipment, software, and services. The assays can be further broken down into bacterial toxicity assay, enzyme toxicity assay, cell-based elisa & western blots, receptor-binding assays, and other assays. Consumables will account for the largest market share during the advent of the forecast owing to increasing demand for a higher quality of reagents and repeated usability. On the basis of technology, the global in-vitro toxicology testing market can be bifurcated into cell culture technology, high throughput technology, molecular imaging & OMICS technology. Cell culture technology is expected to dominate the market during the segment owing to consistency and reproducibility coupled with early detection of toxicity in any drug-based trial. On the basis of method, the global in-vitro toxicology testing market can be broken down into cellular assay, biochemical assay, in silico, and ex-vivo. Cellular assays are expected to dominate the market during the forecast due to contributing factors ranging from easy availability and dependability of these kits.

On the basis of application, the global in-vitro toxicology testing market can be segmented into systemic toxicology, dermal toxicology, endocrine disruption, ocular toxicity, and others. The segment of systemic toxicology is expected to witness the largest market share during the forecast owing to the development of multiple organ plates with simulated blood flow for assessment of systemic toxic drives coupled with rising adoption for replacing animal testing with in-vitro testing. On the basis of end-users, the global in-vitro toxicology testing market can be fragmented into pharmaceutical, cosmetics, and household products, diagnostics, chemicals industry, & food industry. The pharmaceutical sector is expected to contribute to the largest share in the segment owing to the increasing usage of toxicology testing in pharmacokinetic analysis for novel and generic modified pharmaceutical product testing.

Global In-Vitro Toxicology Testing Market: Regional Analysis

Asia-Pacific is expected to occupy the largest market share during the advent of the forecast. Several contributing factors such as an increase in governmental and local organizations protesting against the use of animals during drug trial development as well as ongoing launches of biologics and biosimilar products by biopharmaceutical industries in the region will drive the growth of the market. Additional, increased government funding for drug discovery studies from the government and private sector alike will boost the sales of the in-vitro toxicology treatment market during the forecast. A low testing and cost-effective method in the region and the presence of key players further pushes the state of in-vitro toxicology testing market toward a ballooned state.

Global In-Vitro Toxicology Testing Market: Competitive Players

The key participants in the global in-vitro toxicology testing market are Merck KGaA., Charles River, Bio-Rad Laboratories, Inc., Abbott., Thermo Fisher Scientific, Inc., GE Healthcare, Quest Diagnostic Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentonix, and Agilent Technologies, among others.

Global In-Vitro Toxicology Testing Market: By Product Segment Analysis

  • Consumables
  • Assays
    • Bacterial Toxicity Assay
    • Enzyme Toxicity Assay
    • Cell-Based Elisa & Western Blots
    • Receptor-Binding Assays
    • Other Assays
  • Equipment
  • Software
  • Services

Global In-Vitro Toxicology Testing Market: By Technology Segment Analysis

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

Global In-Vitro Toxicology Testing Market: By Method Segment Analysis

  • Cellular Assay
  • Biochemical Assay
  • In silico
  • Ex-vivo

Global In-Vitro Toxicology Testing Market: By Application Segment Analysis

  • Systemic Toxicology
  • Dermal Toxicology
  • Endocrine Disruption
  • Ocular Toxicity
  • Others

Global In-Vitro Toxicology Testing Market: By End-Users Segment Analysis

  • Pharmaceutical
  • Cosmetics and Household Products
  • Diagnostics,
  • Chemicals Industry
  • Food industry

Global In-Vitro Toxicology Testing Market: By Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable  Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of In-vitro Toxicology Testing
    2. 1.2. Global In-vitro Toxicology Testing Market, 2020 & 2026 (USD Billion)
    3. 1.3. Global In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    4. 1.4. Global In-vitro Toxicology Testing Market Absolute Revenue Opportunity, 2016 – 2026 (USD Billion)
    5. 1.5. Global In-vitro Toxicology Testing Market Incremental Revenue Opportunity, 2020 – 2026 (USD Billion)
  2. Chapter 2 In-vitro Toxicology Testing Market – Product Analysis
    1. 2.1. Global In-vitro Toxicology Testing Market – Product Overview
    2. 2.2. Global In-vitro Toxicology Testing Market Share, by Product, 2020 & 2026 (USD Billion)
    3. 2.3. Consumables
      1. 2.3.1. Global Consumables In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    4. 2.4. Assays
      1. 2.4.1. Global Assays In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    5. 2.5. Equipment
      1. 2.5.1. Global Equipment In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    6. 2.6. Software
      1. 2.6.1. Global Software In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    7. 2.7. Services
      1. 2.7.1. Global Services In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
  3. Chapter 3 In-vitro Toxicology Testing Market – Technology Analysis
    1. 3.1. Global In-vitro Toxicology Testing Market – Technology Overview
    2. 3.2. Global In-vitro Toxicology Testing Market Share, by Technology, 2020 & 2026 (USD Billion)
    3. 3.3. Cell Culture Technology
      1. 3.3.1. Global Cell Culture Technology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    4. 3.4. High Throughput Technology
      1. 3.4.1. Global High Throughput Technology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    5. 3.5. Molecular Imaging
      1. 3.5.1. Global Molecular Imaging In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    6. 3.6. OMICS Technology
      1. 3.6.1. Global OMICS Technology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
  4. Chapter 4 In-vitro Toxicology Testing Market – Method Analysis
    1. 4.1. Global In-vitro Toxicology Testing Market – Method Overview
    2. 4.2. Global In-vitro Toxicology Testing Market Share, by Method, 2020 & 2026 (USD Billion)
    3. 4.3. Cellular Assay
      1. 4.3.1. Global Cellular Assay In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    4. 4.4. Biochemical Assay
      1. 4.4.1. Global Biochemical Assay In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    5. 4.5. In silico
      1. 4.5.1. Global In silico In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    6. 4.6. Ex-vivo
      1. 4.6.1. Global Ex-vivo In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
  5. Chapter 5 In-vitro Toxicology Testing Market – Application Analysis
    1. 5.1. Global In-vitro Toxicology Testing Market – Application Overview
    2. 5.2. Global In-vitro Toxicology Testing Market Share, by Application, 2020 & 2026 (USD Billion)
    3. 5.3. Systemic Toxicology
      1. 5.3.1. Global Systemic Toxicology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    4. 5.4. Dermal Toxicology
      1. 5.4.1. Global Dermal Toxicology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    5. 5.5. Endocrine Disruption
      1. 5.5.1. Global Endocrine Disruption In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    6. 5.6. Ocular Toxicity
      1. 5.6.1. Global Ocular Toxicity In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    7. 5.7. Others
      1. 5.7.1. Global Others In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
  6. Chapter 6 In-vitro Toxicology Testing Market – End-Users Analysis
    1. 6.1. Global In-vitro Toxicology Testing Market – End-Users Overview
    2. 6.2. Global In-vitro Toxicology Testing Market Share, by End-Users, 2020 & 2026 (USD Billion)
    3. 6.3. Pharmaceutical
      1. 6.3.1. Global Pharmaceutical In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    4. 6.4. Cosmetics and Household Products
      1. 6.4.1. Global Cosmetics and Household Products In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    5. 6.5. Diagnostics
      1. 6.5.1. Global Diagnostics In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    6. 6.6. Chemicals Industry
      1. 6.6.1. Global Chemicals Industry In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    7. 6.7. Food industry
      1. 6.7.1. Global Food industry In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
  7. Chapter 7 In-vitro Toxicology Testing Market – Regional Analysis
    1. 7.1. Global In-vitro Toxicology Testing Market Regional Overview
    2. 7.2. Global In-vitro Toxicology Testing Market Share, by Region, 2020 & 2026 (USD Billion)
    3. 7.3. North America
      1. 7.3.1. North America In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
        1. 7.3.1.1. North America In-vitro Toxicology Testing Market, by Country, 2016 - 2026 (USD Billion)
      2. 7.3.2. North America In-vitro Toxicology Testing Market, by Product, 2016 – 2026
        1. 7.3.2.1. North America In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      3. 7.3.3. North America In-vitro Toxicology Testing Market, by Technology, 2016 – 2026
        1. 7.3.3.1. North America In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 7.3.4. North America In-vitro Toxicology Testing Market, by Method, 2016 – 2026
        1. 7.3.4.1. North America In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      5. 7.3.5. North America In-vitro Toxicology Testing Market, by Application, 2016 – 2026
        1. 7.3.5.1. North America In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      6. 7.3.6. North America In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026
        1. 7.3.6.1. North America In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      7. 7.3.7. U.S.
        1. 7.3.7.1. U.S. In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      8. 7.3.8. Canada
        1. 7.3.8.1. Canada In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    4. 7.4. Europe
      1. 7.4.1. Europe In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
        1. 7.4.1.1. Europe In-vitro Toxicology Testing Market, by Country, 2016 - 2026 (USD Billion)
      2. 7.4.2. Europe In-vitro Toxicology Testing Market, by Product, 2016 – 2026
        1. 7.4.2.1. Europe In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      3. 7.4.3. Europe In-vitro Toxicology Testing Market, by Technology, 2016 – 2026
        1. 7.4.3.1. Europe In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 7.4.4. Europe In-vitro Toxicology Testing Market, by Method, 2016 – 2026
        1. 7.4.4.1. Europe In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      5. 7.4.5. Europe In-vitro Toxicology Testing Market, by Application, 2016 – 2026
        1. 7.4.5.1. Europe In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      6. 7.4.6. Europe In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026
        1. 7.4.6.1. Europe In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      7. 7.4.7. Germany
        1. 7.4.7.1. Germany In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      8. 7.4.8. France
        1. 7.4.8.1. France In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      9. 7.4.9. U.K.
        1. 7.4.9.1. U.K. In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      10. 7.4.10. Italy
        1. 7.4.10.1. Italy In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      11. 7.4.11. Spain
        1. 7.4.11.1. Spain In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      12. 7.4.12. Rest of Europe
        1. 7.4.12.1. Rest of Europe In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    5. 7.5. Asia Pacific
      1. 7.5.1. Asia Pacific In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
        1. 7.5.1.1. Asia Pacific In-vitro Toxicology Testing Market, by Country, 2016 - 2026 (USD Billion)
      2. 7.5.2. Asia Pacific In-vitro Toxicology Testing Market, by Product, 2016 – 2026
        1. 7.5.2.1. Asia Pacific In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      3. 7.5.3. Asia Pacific In-vitro Toxicology Testing Market, by Technology, 2016 – 2026
        1. 7.5.3.1. Asia Pacific In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 7.5.4. Asia Pacific In-vitro Toxicology Testing Market, by Method, 2016 – 2026
        1. 7.5.4.1. Asia Pacific In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      5. 7.5.5. Asia Pacific In-vitro Toxicology Testing Market, by Application, 2016 – 2026
        1. 7.5.5.1. Asia Pacific In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      6. 7.5.6. Asia Pacific In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026
        1. 7.5.6.1. Asia Pacific In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      7. 7.5.7. China
        1. 7.5.7.1. China In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      8. 7.5.8. Japan
        1. 7.5.8.1. Japan In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      9. 7.5.9. India
        1. 7.5.9.1. India In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      10. 7.5.10. South Korea
        1. 7.5.10.1. South Korea In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      11. 7.5.11. South-East Asia
        1. 7.5.11.1. South-East Asia In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      12. 7.5.12. Rest of Asia Pacific
        1. 7.5.12.1. Rest of Asia Pacific In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    6. 7.6. Latin America
      1. 7.6.1. Latin America In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
        1. 7.6.1.1. Latin America In-vitro Toxicology Testing Market, by Country, 2016 - 2026 (USD Billion)
      2. 7.6.2. Latin America In-vitro Toxicology Testing Market, by Product, 2016 – 2026
        1. 7.6.2.1. Latin America In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      3. 7.6.3. Latin America In-vitro Toxicology Testing Market, by Technology, 2016 – 2026
        1. 7.6.3.1. Latin America In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 7.6.4. Latin America In-vitro Toxicology Testing Market, by Method, 2016 – 2026
        1. 7.6.4.1. Latin America In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      5. 7.6.5. Latin America In-vitro Toxicology Testing Market, by Application, 2016 – 2026
        1. 7.6.5.1. Latin America In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      6. 7.6.6. Latin America In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026
        1. 7.6.6.1. Latin America In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      7. 7.6.7. Brazil
        1. 7.6.7.1. Brazil In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      8. 7.6.8. Mexico
        1. 7.6.8.1. Mexico In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      9. 7.6.9. Rest of Latin America
        1. 7.6.9.1. Rest of Latin America In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
    7. 7.7. The Middle-East and Africa
      1. 7.7.1. The Middle-East and Africa In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
        1. 7.7.1.1. The Middle-East and Africa In-vitro Toxicology Testing Market, by Country, 2016 - 2026 (USD Billion)
      2. 7.7.2. The Middle-East and Africa In-vitro Toxicology Testing Market, by Product, 2016 – 2026
        1. 7.7.2.1. The Middle-East and Africa In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      3. 7.7.3. The Middle-East and Africa In-vitro Toxicology Testing Market, by Technology, 2016 – 2026
        1. 7.7.3.1. The Middle-East and Africa In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      4. 7.7.4. The Middle-East and Africa In-vitro Toxicology Testing Market, by Method, 2016 – 2026
        1. 7.7.4.1. The Middle-East and Africa In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      5. 7.7.5. The Middle-East and Africa In-vitro Toxicology Testing Market, by Application, 2016 – 2026
        1. 7.7.5.1. The Middle-East and Africa In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      6. 7.7.6. The Middle-East and Africa In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026
        1. 7.7.6.1. The Middle-East and Africa In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      7. 7.7.7. GCC Countries
        1. 7.7.7.1. GCC Countries In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      8. 7.7.8. South Africa
        1. 7.7.8.1. South Africa In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      9. 7.7.9. Rest of Middle-East Africa
        1. 7.7.9.1. Rest of Middle-East Africa In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
  8. Chapter 8 In-vitro Toxicology Testing Market – Competitive Landscape
    1. 8.1. Competitor Market Share – Revenue
    2. 8.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 8.3. Strategic Developments
      1. 8.3.1. Acquisitions and Mergers
      2. 8.3.2. New Products
      3. 8.3.3. Research & Development Activities
  9. Chapter 9 Company Profiles
    1. 9.1. Merck KGaA
      1. 9.1.1. Company Overview
      2. 9.1.2. Product/Service Portfolio
      3. 9.1.3. Merck KGaA Sales, Revenue, and Gross Margin
      4. 9.1.4. Merck KGaA Revenue and Growth Rate
      5. 9.1.5. Merck KGaA Market Share
      6. 9.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 9.2. Charles River
      1. 9.2.1. Company Overview
      2. 9.2.2. Product/Service Portfolio
      3. 9.2.3. Charles River Sales, Revenue, and Gross Margin
      4. 9.2.4. Charles River Revenue and Growth Rate
      5. 9.2.5. Charles River Market Share
      6. 9.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 9.3. Bio-Rad Laboratories Inc
      1. 9.3.1. Company Overview
      2. 9.3.2. Product/Service Portfolio
      3. 9.3.3. Bio-Rad Laboratories Inc Sales, Revenue, and Gross Margin
      4. 9.3.4. Bio-Rad Laboratories Inc Revenue and Growth Rate
      5. 9.3.5. Bio-Rad Laboratories Inc Market Share
      6. 9.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 9.4. Abbott
      1. 9.4.1. Company Overview
      2. 9.4.2. Product/Service Portfolio
      3. 9.4.3. Abbott Sales, Revenue, and Gross Margin
      4. 9.4.4. Abbott Revenue and Growth Rate
      5. 9.4.5. Abbott Market Share
      6. 9.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 9.5. Thermo Fisher Scientific Inc
      1. 9.5.1. Company Overview
      2. 9.5.2. Product/Service Portfolio
      3. 9.5.3. Thermo Fisher Scientific Inc Sales, Revenue, and Gross Margin
      4. 9.5.4. Thermo Fisher Scientific Inc Revenue and Growth Rate
      5. 9.5.5. Thermo Fisher Scientific Inc Market Share
      6. 9.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 9.6. GE Healthcare
      1. 9.6.1. Company Overview
      2. 9.6.2. Product/Service Portfolio
      3. 9.6.3. GE Healthcare Sales, Revenue, and Gross Margin
      4. 9.6.4. GE Healthcare Revenue and Growth Rate
      5. 9.6.5. GE Healthcare Market Share
      6. 9.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 9.7. Quest Diagnostic Incorporated
      1. 9.7.1. Company Overview
      2. 9.7.2. Product/Service Portfolio
      3. 9.7.3. Quest Diagnostic Incorporated Sales, Revenue, and Gross Margin
      4. 9.7.4. Quest Diagnostic Incorporated Revenue and Growth Rate
      5. 9.7.5. Quest Diagnostic Incorporated Market Share
      6. 9.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 9.8. Eurofins Scientific
      1. 9.8.1. Company Overview
      2. 9.8.2. Product/Service Portfolio
      3. 9.8.3. Eurofins Scientific Sales, Revenue, and Gross Margin
      4. 9.8.4. Eurofins Scientific Revenue and Growth Rate
      5. 9.8.5. Eurofins Scientific Market Share
      6. 9.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 9.9. Laboratory Corporation of America Holdings
      1. 9.9.1. Company Overview
      2. 9.9.2. Product/Service Portfolio
      3. 9.9.3. Laboratory Corporation of America Holdings Sales, Revenue, and Gross Margin
      4. 9.9.4. Laboratory Corporation of America Holdings Revenue and Growth Rate
      5. 9.9.5. Laboratory Corporation of America Holdings Market Share
      6. 9.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 9.10. Evotec
      1. 9.10.1. Company Overview
      2. 9.10.2. Product/Service Portfolio
      3. 9.10.3. Evotec Sales, Revenue, and Gross Margin
      4. 9.10.4. Evotec Revenue and Growth Rate
      5. 9.10.5. Evotec Market Share
      6. 9.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 9.11. Creative Bioarray
      1. 9.11.1. Company Overview
      2. 9.11.2. Product/Service Portfolio
      3. 9.11.3. Creative Bioarray Sales, Revenue, and Gross Margin
      4. 9.11.4. Creative Bioarray Revenue and Growth Rate
      5. 9.11.5. Creative Bioarray Market Share
      6. 9.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 9.12. Gentonix
      1. 9.12.1. Company Overview
      2. 9.12.2. Product/Service Portfolio
      3. 9.12.3. Gentonix Sales, Revenue, and Gross Margin
      4. 9.12.4. Gentonix Revenue and Growth Rate
      5. 9.12.5. Gentonix Market Share
      6. 9.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    13. 9.13. Agilent Technologies
      1. 9.13.1. Company Overview
      2. 9.13.2. Product/Service Portfolio
      3. 9.13.3. Agilent Technologies Sales, Revenue, and Gross Margin
      4. 9.13.4. Agilent Technologies Revenue and Growth Rate
      5. 9.13.5. Agilent Technologies Market Share
      6. 9.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  10. Chapter 10 In-vitro Toxicology Testing — Industry Analysis
    1. 10.1. Introduction and Taxonomy
    2. 10.2. In-vitro Toxicology Testing Market – Key Trends
      1. 10.2.1. Market Drivers
      2. 10.2.2. Market Restraints
      3. 10.2.3. Market Opportunities
    3. 10.3. Value Chain Analysis
    4. 10.4. Key Mandates and Regulations
    5. 10.5. Technology Roadmap and Timeline
    6. 10.6. In-vitro Toxicology Testing Market – Attractiveness Analysis
      1. 10.6.1. By Product
      2. 10.6.2. By Technology
      3. 10.6.3. By Method
      4. 10.6.4. By Application
      5. 10.6.5. By End-Users
      6. 10.6.6. By Region
  11. Chapter 11 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 11.1. In-vitro Toxicology Testing Industrial Chain Analysis
    2. 11.2. Downstream Buyers
    3. 11.3. Distributors/Traders List
  12. Chapter 12 Marketing Strategy Analysis
    1. 12.1. Marketing Channel
    2. 12.2. Direct Marketing
    3. 12.3. Indirect Marketing
    4. 12.4. Marketing Channel Development Trends
    5. 12.5. Economic/Political Environmental Change
  13. Chapter 13 Report Conclusion & Key Insights
    1. 13.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 13.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  14. Chapter 14 Research Approach & Methodology
    1. 14.1. Report Description
    2. 14.2. Research Scope
    3. 14.3. Research Methodology
      1. 14.3.1. Secondary Research
      2. 14.3.2. Primary Research
      3. 14.3.3. Statistical Models
        1. 14.3.3.1. Company Share Analysis Model
        2. 14.3.3.2. Revenue Based Modeling
      4. 14.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of In-vitro Toxicology Testing
      Fig.2	Global In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.3	Global In-vitro Toxicology Testing Market Absolute Revenue Opportunity, 2016 – 2026 (USD Billion)
      Fig.4	Global In-vitro Toxicology Testing Market Incremental Revenue Opportunity, 2020 – 2026 (USD Billion)
      Fig.5	Global In-vitro Toxicology Testing Market Share, by Product, 2020 & 2026 (USD Billion)
      Fig.6	Global Consumables In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.7	Global Assays In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.8	Global Equipment In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.9	Global Software In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.10	Global Services In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.11	Global In-vitro Toxicology Testing Market Share, by Technology, 2020 & 2026 (USD Billion)
      Fig.12	Global Cell Culture Technology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.13	Global High Throughput Technology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.14	Global Molecular Imaging  In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.15	Global OMICS Technology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.16	Global In-vitro Toxicology Testing Market Share, by Method, 2020 & 2026 (USD Billion)
      Fig.17	Global Cellular Assay In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.18	Global Biochemical Assay In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.19	Global In silico In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.20	Global Ex-vivo In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.21	Global In-vitro Toxicology Testing Market Share, by Application, 2020 & 2026 (USD Billion)
      Fig.22	Global Systemic Toxicology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.23	Global Dermal Toxicology In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.24	Global Endocrine Disruption In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.25	Global Ocular Toxicity In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.26	Global Others In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.27	Global In-vitro Toxicology Testing Market Share, by End-Users, 2020 & 2026 (USD Billion)
      Fig.28	Global Pharmaceutical In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.29	Global Cosmetics and Household Products In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.30	Global Diagnostics In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.31	Global Chemicals Industry  In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.32	Global Food industry In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.33	Global In-vitro Toxicology Testing Market Share, by Region, 2020 & 2026 (USD Billion)
      Fig.34	North America In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.35	U.S. In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.36	Canada In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.37	Europe In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.38	Germany In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.39	France In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.40	U.K. In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.41	Italy In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.42	Spain In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.43	Rest of Europe In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.44	Asia Pacific In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.45	China In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.46	Japan In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.47	India In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.48	South  Korea In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.49	South-East Asia In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.50	Rest of Asia Pacific In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.51	Latin America In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.52	Brazil In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.53	Mexico In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.54	Rest of Latin America In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.55	The Middle-East and Africa In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.56	GCC Countries In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.57	South Africa In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.58	Rest of Middle-East Africa In-vitro Toxicology Testing Market, 2016 – 2026 (USD Billion)
      Fig.59	Competitor Market Share – Revenue
      Fig.60	Merck KGaA Revenue and Growth Rate
      Fig.61	Merck KGaA Market Share
      Fig.62	Charles River Revenue and Growth Rate
      Fig.63	Charles River Market Share
      Fig.64	Bio-Rad Laboratories Inc Revenue and Growth Rate
      Fig.65	Bio-Rad Laboratories Inc Market Share
      Fig.66	Abbott Revenue and Growth Rate
      Fig.67	Abbott Market Share
      Fig.68	Thermo Fisher Scientific Inc Revenue and Growth Rate
      Fig.69	Thermo Fisher Scientific Inc Market Share
      Fig.70	GE Healthcare Revenue and Growth Rate
      Fig.71	GE Healthcare Market Share
      Fig.72	Quest Diagnostic Incorporated Revenue and Growth Rate
      Fig.73	Quest Diagnostic Incorporated Market Share
      Fig.74	Eurofins Scientific Revenue and Growth Rate
      Fig.75	Eurofins Scientific Market Share
      Fig.76	Laboratory Corporation of America Holdings Revenue and Growth Rate
      Fig.77	Laboratory Corporation of America Holdings Market Share
      Fig.78	Evotec Revenue and Growth Rate
      Fig.79	Evotec Market Share
      Fig.80	Creative Bioarray Revenue and Growth Rate
      Fig.81	Creative Bioarray Market Share
      Fig.82	Gentonix Revenue and Growth Rate
      Fig.83	Gentonix Market Share
      Fig.84	Agilent Technologies Revenue and Growth Rate
      Fig.85	Agilent Technologies Market Share
      Fig.86	Market Dynamics
      Fig.87	Global In-vitro Toxicology Testing – Value Chain Analysis
      Fig.88	Key Mandates and Regulations
      Fig.89	Technology Roadmap and Timeline
      Fig.90	Market Attractiveness Analysis – By Product
      Fig.91	Market Attractiveness Analysis – By Technology
      Fig.92	Market Attractiveness Analysis – By Method
      Fig.93	Market Attractiveness Analysis – By Application
      Fig.94	Market Attractiveness Analysis – By End-Users
      Fig.95	Market Attractiveness Analysis – By Region
      Fig.96	In-vitro Toxicology Testing Industrial Chain Analysis
      Fig.97	Market Channels
      Fig.98	Marketing Channel Development Trend
      Fig.99	Growth in World Gross Product, 2008-2018
      

      List of Tables

      Table 1	Global In-vitro Toxicology Testing Market, 2020 & 2026 (USD Billion)
      Table 2	Global In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      Table 3	Global In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      Table 4	Global In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      Table 5	Global In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      Table 6	Global In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      Table 7	Global In-vitro Toxicology Testing Market, by Region, 2016 – 2026 (USD Billion)
      Table 8	North America In-vitro Toxicology Testing Market, by Country, 2016 – 2026 (USD Billion)
      Table 9	North America In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      Table 10 North America In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      Table 11 North America In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      Table 12 North America In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      Table 13 North America In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      Table 14 Europe In-vitro Toxicology Testing Market, by Country, 2016 – 2026 (USD Billion)
      Table 15 Europe In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      Table 16 Europe In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      Table 17 Europe In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      Table 18 Europe In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      Table 19 Europe In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      Table 20 Asia Pacific In-vitro Toxicology Testing Market, by Country, 2016 – 2026 (USD Billion)
      Table 21 Asia Pacific In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      Table 22 Asia Pacific In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      Table 23 Asia Pacific In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      Table 24 Asia Pacific In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      Table 25 Asia Pacific In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      Table 26 Latin America In-vitro Toxicology Testing Market, by Country, 2016 – 2026 (USD Billion)
      Table 27 Latin America In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      Table 28 Latin America In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      Table 29 Latin America In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      Table 30 Latin America In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      Table 31 Latin America In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      Table 32 The Middle-East and Africa In-vitro Toxicology Testing Market, by Country, 2016 – 2026 (USD Billion)
      Table 33 The Middle-East and Africa In-vitro Toxicology Testing Market, by Product, 2016 – 2026 (USD Billion)
      Table 34 The Middle-East and Africa In-vitro Toxicology Testing Market, by Technology, 2016 – 2026 (USD Billion)
      Table 35 The Middle-East and Africa In-vitro Toxicology Testing Market, by Method, 2016 – 2026 (USD Billion)
      Table 36 The Middle-East and Africa In-vitro Toxicology Testing Market, by Application, 2016 – 2026 (USD Billion)
      Table 37 The Middle-East and Africa In-vitro Toxicology Testing Market, by End-Users, 2016 – 2026 (USD Billion)
      Table 38 Global In-vitro Toxicology Testing Market - Company Revenue Analysis, 2016 – 2020 (USD Billion)
      Table 39 Global In-vitro Toxicology Testing Market - Company Revenue Share Analysis, 2016 – 2020 (%)
      Table 40 Acquisitions and Mergers
      Table 41 Market Drivers – Impact Analysis
      Table 42 Market Restraints
      Table 43 Market Opportunities
      Table 44 Major Buyers of In-vitro Toxicology Testing
      Table 45 Distributors/Traders of In-vitro Toxicology Testing by Region
      

Industry Major Market Players

  • Merck KGaA.
  • Charles River
  • Bio-Rad Laboratories Inc.
  • Abbott.
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Quest Diagnostic Incorporated
  • Eurofins Scientific
  • Laboratory Corporation of America Holdings
  • Evotec
  • Creative Bioarray
  • Gentonix
  • Agilent Technologies

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions